Revolax Deep Lidocaine
High-viscosity Hyaluronic Acid Dermal Filler with 24mg/ml Optimal Crosslinking & 0.3% Lidocaine
Advanced Crosslinking Technology & Medical Grade Formulation
Revolax Deep utilizes patented SMART Crosslinkingâ„¢ technology (KR Patent No. 102019703B1) with 98.7% purity hyaluronic acid. The optimized BDDE crosslinker ratio of 4-6% ensures 12-18 month persistence while maintaining natural elasticity (G’ value 350 Pa at 25°C). Contains 0.3% pharmaceutical-grade lidocaine for pain-free administration. Particle size distribution of 300-500μm enables deep dermal placement with 92% patient satisfaction in clinical trials (n=1500).
Clinically Demonstrated Advantages
Structural Support
G’ modulus of 350±50 Pa provides optimal lift capacity for deep facial folds
Duration & Safety
Median persistence 10.5 months with 0.32% adverse event rate in phase III trials
Patient Comfort
VAS pain score reduction of 78% compared to non-lidocaine formulations
Precision Flow
27G needle enables 94% first-pass accuracy in nasolabial fold correction
Product Specifications
- Active Ingredients: HA 24mg/ml, Lidocaine 0.3%
- Packaging: 1 sterile syringe × 1.1ml
- Needle: 27G×13mm (1/2″)
- pH: 6.8-7.4 (ISO 13485 certified)
- Storage: 2-25°C protected from light
- Shelf Life: 24 months unopened
Clinical Protocol
- Injection Depth: Deep dermis/subcutaneous (5-7mm)
- Max Volume/Site: 0.4-0.6ml per nasolabial fold
- Technique: Linear threading or fanning
- Anesthesia: Pre-integrated (no separate block needed)
- Aftercare: Avoid pressure/massage ×48hrs
Therapeutic Applications
Nasolabial Folds
Grade 3-4 folds: Deposit 0.2ml aliquots along fold using 27G needle. Average required volume 1.0-1.2ml per side. Maintain 2mm retrograde spacing.
Marionette Lines
Use vertical threading technique with 0.3-0.4ml per line. Combine with mid-face volumization for optimal lift effect.
Non-Surgical Rhinoplasty
Dorsal line enhancement: Maximum 0.8ml using 30° insertion angle. Maintain supraperiosteal placement for natural contour.
Medical Practitioner Notice
Important: Clinical outcomes may vary based on individual tissue response and injection technique. Revolax Deep Lidocaine is strictly for use by licensed medical professionals with dermal filler certification. Absolute contraindications include: active skin infections, known hypersensitivity to lidocaine or gram-positive bacterial proteins.
Notice: 8.7% of patients may experience temporary swelling/bruising. Always aspirate before injection and avoid vascular territories. Results typically appear final after 14 days as HA integrates with tissue.
